Navigation Links
Navigating the Patent Minefield of Embryonic Stem Cell Product Development; Free Kindle Fire Tablet and Research Database with Purchase

FARMINGTON, Conn., May 31, 2012 /PRNewswire-iReach/ -- BioInformant's two newest market researchs report offers mission-critical insight into the complex but lucrative world of embryonic stem cell product development and patent licensing. To promote these excellent products, Global Information Inc is offering our first 10 customers an Amazon Kindle Fire tablet with their purchase, as well as a copy of BioInformant's 2012 Marketing Database of Stem Cell Researchers, a combined $1500 value, absolutely free.


Error-Proof Entry, Expert Positioning, and Exploding Growth in Embryonic Stem Cell Products

Companies interested in developing human embryonic stem cell products have to navigate a risky product environment. Due to the long-standing and controversial patents held by the University of Wisconsin's Alumni Research Foundation (WARF), companies have been largely hindered by the intellectual property (IP) environment restricting the development of embryonic stem cell products.  However, going where competitors fear to tread means tremendous financial rewards are available for the companies that move boldly forward.

Human embryonic stem cells offer tremendous therapeutic potential, as they can develop into over 200 different cell types. However, up until now, WARF has had the power to largely control what companies can develop embryonic stem cell products and on what terms. With the release of BioInformant's report Error-Proof Entry, Expert Positioning, and Exploding Growth in Embryonic Stem Cell Products, published June 2012, research supply companies can now receive clear guidance for navigating the hazards of embryonic stem cell product development.

The report reveals critical alternatives to traditional WARF licensing, such as moving research overseas, establishing collaborations with companies that are existing WARF licensees, structuring creative negotiating alternatives, developing products for other species – and other breakthrough strategies.

BioInformant's report also offers historical and future growth projections for the embryonic stem cell product market, competitive analysis of existing providers, and detailed assessment of creative strategies for developing high-demand products.  This insight is possible, because BioInformant has been the global leader in stem cell industry data since 2006 and is the only producer of market intelligence data specific for the stem cell sector.

Free samples from the full document are available at:

Stem Cell Research Products - Opportunities, Tools, and Technologies

Staying ahead of a hungry and fast moving pack of competitors requires the very best market insights, and BioInformant also offers a sophisticated market intelligence report for the stem cell research supply market.

Whether you already supply stem cell research products or you wish to expand your product line, you'll know just how essential and lucrative this market is. We know you want to make effective product development decisions, to sell more effectively to scientists, to generate improved revenues and take market share from your competition.

Stem Cell Research Products - Opportunities, Tools, and Technologies - published in May 2012 - shows you how to do just that. Helping you understand the prevailing market conditions and giving you guidance to strategically position and develop stem cell product lines.

So when you choose our industry-leading market report, you'll be gaining a competitive advantage in three core areas.

To see the details of those core areas, and to view free samples from the full document, please visit the report page at:

About Global Information Inc. - Global Information (GII) ( is an information service company partnering with over 300 research companies around the world. Global Information has been in the business of distributing technical and market research for more than 25 years. Expanded from its original headquarters in Japan, Global Information now has offices in Korea, Taiwan, Singapore, Europe and the United States.

Media Contact: Jeremy Palaia, Global Information, Inc., 1-860-674-8796,

News distributed by PR Newswire iReach:

SOURCE Global Information, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology news :

1. Navigating the IP Minefield of Human Embryonic Stem Cell Development
2. Navigating in the ocean of molecules
3. Medbox Developing a Patent Pending Wall-Mounted Biometric Kiosk for Storage of Sensitive Medicine Samples and Supplies for Doctors Offices.
4. How will the US biotechnology industry benefit from new patent laws?
5. NJIT professor awarded patent today for new desalination devices, more
6. Improved Authentication and Confidentiality Protection. ICAP Patent Brokerage Announces for Auction Important Patents in Data Encryption and Document Security
7. Alnylam and UMass Medical School announce Tuschl I patent upheld in European opposition proceedings
8. IVI granted 2 US patents on dysentery vaccine inventions
9. St. Michaels and King Saud University receive first joint patent
10. Psychemedics Awarded Patent Fundamental To Hair Analysis Drug Testing
11. UCF patented on induced pluripotent stem cells, iPS cells
Post Your Comments:
(Date:10/4/2017)... Solutions, a global clinical research organization (CRO), announces the launch of ... 4, 2017. Shadow is designed to assist medical writers and biometrics ... the European Medicines Agency (EMA) in meeting the requirements for de-identifying ... ... ...
(Date:7/20/2017)... 20, 2017 Delta (NYSE: DAL ) customers now ... aircraft at Reagan Washington National Airport (DCA). ... Delta launches biometrics to board aircraft at ... Delta,s biometric boarding pass experience ... is now integrated into the boarding process to allow eligible Delta SkyMiles ...
(Date:6/14/2017)... (NYSE: IBM ) is introducing several innovative partner startups ... collaboration between startups and global businesses, taking place in ... nine startups will showcase the solutions they have built with ... France is one of the ... percent increase in the number of startups created between 2012 ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... CA (PRWEB) , ... October ... ... ( ) has launched Rosalind™, the first-ever genomics analysis platform specifically designed ... bioinformatics complexity. Named in honor of pioneering researcher Rosalind Franklin, who made ...
(Date:10/11/2017)... ... 2017 , ... ComplianceOnline’s Medical Device Summit is back for its 4th year. ... San Francisco, CA. The Summit brings together current and former FDA office bearers, regulators, ... government officials from around the world to address key issues in device compliance, quality ...
(Date:10/11/2017)... ... ... Disappearing forests and increased emissions are the main causes of the evolving ... those living in larger cities are affected by air pollution related diseases. , That ... countries globally - decided to take action. , “I knew I had to take ...
(Date:10/10/2017)... Los Angeles, CA (PRWEB) , ... ... ... Pharmaceuticals, Inc., a development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) ... all uses of targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed ...
Breaking Biology Technology: